Literature DB >> 2032218

Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.

D R Hofer1, E R Sherwood, W D Bromberg, J Mendelsohn, C Lee, J M Kozlowski.   

Abstract

The androgen-independent prostatic carcinoma cell line PC3 is known to exhibit autonomous growth in vitro and in vivo. The purpose of the present study was to investigate the role of transforming growth factor alpha (TGF-alpha) and its receptor, the epidermal growth factor (EGF) receptor, in the regulation of PC3 cell proliferation. Results showed that PC3 cells secrete factors into conditioned medium that are mitogenic for the less aggressive prostatic carcinoma lines DU145 and LNCaP. Gel filtration chromatography of PC3-conditioned medium revealed a major peak of mitogenic activity at a molecular weight of 5,000 to 10,000 which was inhibited by the addition of antibody to TGF-alpha. The synthesis and secretion of TGF-alpha by PC3 cells were further demonstrated by immunoblotting and radioimmunoassay. Radioreceptor analysis showed a single class (Kd 5.3 nM) of EGF receptors on PC3 cells. The presence of Mr 170,000 EGF receptors on PC3 cells was further demonstrated by immunoprecipitation of metabolically labeled proteins. TGF-alpha was effective in stimulating the growth of low-density, but not high-density, PC3 cultures. In addition, the proliferation of PC3 cells under serum-free defined conditions was inhibited by antibodies to TGF-alpha and/or the EGF receptor. These data indicate that TGF-alpha/EGF receptor interactions are partially responsible for autonomous growth of the PC3 cell line and may explain one mechanism of escape from androgen-dependent growth in human prostatic carcinoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032218

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.

Authors:  Soha Salama El Sheikh; Jan Domin; Paul Abel; Gordon Stamp; El-Nasir Lalani
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

2.  Functional inactivation of Rb sensitizes cancer cells to TSC2 inactivation induced cell death.

Authors:  Arpad M Danos; Yang Liao; Xuan Li; Wei Du
Journal:  Cancer Lett       Date:  2012-09-27       Impact factor: 8.679

Review 3.  Growth factors as mediators of androgen action during the development of the male urogenital tract.

Authors:  G R Cunha; B Foster; A Thomson; Y Sugimura; N Tanji; M Tsuji; N Terada; P W Finch; A A Donjacour
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

4.  Electrolytic valving isolation of cell co-culture microenvironment with controlled cell pairing ratios.

Authors:  Yu-Chih Chen; Patrick Ingram; Euisik Yoon
Journal:  Analyst       Date:  2014-12-21       Impact factor: 4.616

5.  Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.

Authors:  X Wu; Z Fan; H Masui; N Rosen; J Mendelsohn
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.

Authors:  Lorella Bonaccorsi; Sara Marchiani; Monica Muratori; Gianni Forti; Elisabetta Baldi
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-16       Impact factor: 4.553

7.  Autocrine growth stimulation of SW403 colon carcinoma cell line is caused by transforming-growth-factor-alpha-mediated epidermal growth factor receptor activation.

Authors:  T Hirsch; S Eggstein; S Frank; E Farthmann; B U von Specht
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

8.  Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.

Authors:  K Z Ching; E Ramsey; N Pettigrew; R D'Cunha; M Jason; J G Dodd
Journal:  Mol Cell Biochem       Date:  1993-09-22       Impact factor: 3.396

9.  Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition.

Authors:  Jubilee R Stewart; Catherine A O'Brian
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

Review 10.  Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate.

Authors:  E R Sherwood; C Lee
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.